We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App





Abbott Highlights Point of Care Management Solutions

By LabMedica International staff writers
Posted on 31 Jan 2019
Abbott Diagnostics (Lake Forest, IL) highlighted its AegisPOC Point of Care Management Solutions at MedLab Middle East 2019 held in Dubai, UAE, from February 4-7, 2019. More...
MedLab Middle East is a leading laboratory and flagship exhibition and conference spanning across the Middle East, Asia and West Europe, which encompasses event for every specialism within the laboratory management and diagnostics spectrum.

At MedLab 2019, Abbott highlighted the AegisPOC Point of Care Management Solutions, which has been developed to seamlessly connect point-of-care (POC) devices in the hospital or community with the laboratory. A web-based, open platform, AegisPOC allows users to better manage and share data from their POC devices from multiple brands on one flexible, scalable middleware. AegisPOC provides the ability to integrate POC devices with LIS, HIS, EMR, quality management, user management and other systems.

With AegisPOC in place, the laboratory becomes the hub for the entire system – making it easier to share test results among locations and manage patient test results from all locations. AegisPOC reduces the workload required to manage POC devices. Users can automatically, remotely manage quality control for the whole system, along with automating user certification and re-certification training. AegisPOC brings all POC devices together seamlessly, improving data management capabilities and eliminating the need for multiple propriety middleware.


Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Serological Pipet Controller
PIPETBOY GENIUS
New
Automated PCR Setup
ESTREAM
New
Autoimmune Disease Diagnostic
Chorus ds-DNA-G
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more

Pathology

view channel
These images illustrate how precision oncology Organ Chips recapitulate individual patients’ responses to chemotherapy (Photo courtesy of Wyss Institute at Harvard University)

Cancer Chip Accurately Predicts Patient-Specific Chemotherapy Response

Esophageal adenocarcinoma (EAC), one of the two primary types of esophageal cancer, ranks as the sixth leading cause of cancer-related deaths worldwide and currently lacks effective targeted therapies.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.